The 2024 summit, provided invaluable insights into the future of Latino healthcare, offering innovative strategies to navigate the next five years and beyond. Bringing together a diverse range of healthcare professionals, the event sparked dynamic discussions on addressing the pressing health challenges within Latino communities, shaping a brighter future for healthcare equity and representation.
In 2024, the National Hispanic Medical Association and the National Hispanic Health Foundation proudly marked 30 years of relentless dedication to promoting health equity and enhancing Latino representation in healthcare. This milestone grants us the perfect opportunity to craft a strong vision for ourselves as we tackle the critical health challenges facing Latino communities.
Our annual gathering was a vibrant convergence of practicing physicians, dedicated educators, medical residents, passionate researchers, and seasoned healthcare experts. Together, we vigorously advocated for greater inclusion in medical education, expanded professional opportunities, and unparalleled access to top-notch healthcare for the Latino community.
This was an amazing opportunity to play a pivotal role in shaping the future of healthcare for years to come. Thank you for joining us on this journey toward a brighter healthcare future!
40 UNDER 40
The National Hispanic Medical Association and National Hispanic Health Foundation are proud to celebrate the outstanding achievements of 40 exemplary medical professionals! View our complete list below to learn more about these leaders in Hispanic health.
Featured Speaker
Dr. Martin Mendoza, PhD
Director of Health Equity, All of Us Research Program at National Institutes of Health
Plenary Breakfast A: Clinical Trials Diversity
Martin Mendoza, PhD., serves as the director of health equity for the All of Us Research Program. In this role, he provides leadership and high-level expertise to improve inclusion and equity in precision medicine and leads the program’s efforts to promote health equity.
Before joining All of Us, Martin led research for minority health in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). He is a recognized expert in clinical trial diversity and has testified on it before Congress. He is also the primary author of the pivotal FDA guidance recommending that clinical trial sponsors be required to submit a diversity and inclusion plan to FDA. Martin’s original idea and recommendation became federal law in December 2022.
Martin is a graduate of the University of Maryland, Baltimore County, and received his Ph.D. in cancer biology from Johns Hopkins University.
Learn more about our Featured Speakers for the 30th Anniversary Celebration & Leadership Summit:
QUESTIONS?
Please contact our Meetings and Events Manager, LaShawn Maloy at [email protected].
|
